Search results for "3a"

showing 10 items of 351 documents

Modulated neural processing of Western harmony in folk musicians

2013

A chord deviating from the conventions of Western tonal music elicits an early right anterior negativity (ERAN) in inferofrontal brain regions. Here, we tested whether the ERAN is modulated by expertise in more than one music culture, as typical of folk musicians. Finnish folk musicians and nonmusicians participated in electroencephalography recordings. The cadences consisted of seven chords. In incongruous cadences, the third, fifth, or seventh chord was a Neapolitan. The ERAN to the Neapolitans was enhanced in folk musicians compared to nonmusicians. Folk musicians showed an enhanced P3a for the ending Neapolitan. The Neapolitan at the fifth position was perceived differently and elicited…

Cognitive Neurosciencemedia_common.quotation_subjectExperimental and Cognitive Psychology050105 experimental psychology03 medical and health sciencesP3a0302 clinical medicineDevelopmental NeurosciencePerception0501 psychology and cognitive sciencesLearning memoryBiological Psychiatrymedia_commonHarmony (color)Endocrine and Autonomic SystemsGeneral Neuroscience05 social sciencesNegativity effectNeuropsychology and Physiological PsychologyNeurologyNeural processingChord (music)Psychology030217 neurology & neurosurgeryRight anteriorCognitive psychologyPsychophysiology
researchProduct

Pharmacokinetic interaction between efavirenz and ketoconazole in rats

2009

It is well known that efavirenz and ketoconazole act as an inducer and inhibitor of CYP3A4, respectively. As a result of these actions, co-administration of these drugs may result in changes in the pharmacoki- netic parameters of one or both of them. 2. Duodenum-cannulated rats have been used to compare the effect of intraduodenal (KC i.d. ) and intrave- nous administration of ketoconazole (KC i.v. ) on the pharmacokinetics of efavirenz after intraduodenal administration, as well as the potential effect of efavirenz as a CYP450 inducer on ketoconazole phar - macokinetic profile. 3. While KC i.v. did not show any significant effect on efavirenz pharmacokinetic profile, KC i.d. increased sig-…

CyclopropanesMalemedicine.medical_specialtyAntifungal AgentsEfavirenzAnti-HIV AgentsHealth Toxicology and MutagenesisPharmacologyToxicologyBiochemistryEnteral administrationDrug Administration SchedulePeak concentrationchemistry.chemical_compoundCytochrome P-450 Enzyme SystemPharmacokineticsimmune system diseasesInternal medicinemedicineAnimalsCytochrome P-450 CYP3ACytochrome P-450 Enzyme InhibitorsDrug InteractionsInducerRats WistarPharmacologyCYP3A4Chemistryvirus diseasesGeneral MedicineBenzoxazinesRatsKetoconazoleEndocrinologyAlkynesKetoconazolePharmacokinetic interactionmedicine.drugXenobiotica
researchProduct

Coordinated induction of drug transporters and phase I and II metabolism in human liver slices

2008

Although regulation of phase I drug metabolism in human liver is relatively well studied, the regulation of phase II enzymes and of drug transporters is incompletely characterized. Therefore, we used human liver slices to investigate the PXR, CAR and AhR-mediated induction of drug transporters and phase I and II metabolic enzymes. Precision-cut human liver slices were incubated for 5 or 24 h with prototypical inducers: phenobarbital (PB) (50 mu M) for CAR, beta-naphthoflavone (BNF) (25 mu M) for AhR, and rifampicin (RIF) (10 mu M) for PXR, and gene expression of the phase I enzymes CYP1A1, 1A2, 3A4, 3A5, 2136, 2A6, the phase II enzymes UGT1A1 and 1A6, and the transporters MRP2, MDR1, BSEP, …

DIFFERENTIAL REGULATIONQUANTITATIVE RT-PCRRAT-LIVERGene ExpressionPharmaceutical Sciencedrug transportersIn Vitro TechniquesPharmacologydigestive systemCytochrome P-450 Enzyme SystemUDP-GLUCURONOSYLTRANSFERASE 1A1Constitutive androstane receptorHumansSTELLATE CELL ACTIVATIONEnzyme inducerinductionliver slicesCONSTITUTIVE ANDROSTANE RECEPTORchemistry.chemical_classificationPregnane X receptorbiologyCYP3A4Multidrug resistance-associated protein 2TransporterPRIMARY HUMAN HEPATOCYTESMetabolic Detoxication Phase IIdrug metabolismEnzymeLiverPharmaceutical PreparationsBiochemistrychemistryEnzyme Inductionbiology.proteinMetabolic Detoxication Phase IPREGNANE-X-RECEPTORCarrier ProteinsPROTOTYPICAL INDUCERSDrug metabolismBILE-ACIDEuropean Journal of Pharmaceutical Sciences
researchProduct

A loop involving NRF2, miR‐29b‐1‐5p and AKT, regulates cell fate of MDA‐MB‐231 triple‐negative breast cancer cells

2019

The present study shows that nuclear factor erythroid 2-related factor 2 (NRF2) and miR-29b-1-5p are two opposite forces which could regulate the fate of MDA-MB-231 cells, the most studied triple-negative breast cancer (TNBC) cell line. We show that NRF2 activation stimulates cell growth and markedly reduces reactive oxygen species (ROS) generation, whereas miR-29b-1-5p overexpression increases ROS generation and reduces cell proliferation. Moreover, NRF2 downregulates miR-29b-1-5p expression, whereas miR-29b-1-5p overexpression decreases p-AKT and p-NRF2. Furthermore, miR-29b-1-5p overexpression induces both inhibition of DNA N-methyltransferases (DNMT1, DNMT3A, and DNMT3B) expression and …

DNA (Cytosine-5-)-Methyltransferase 10301 basic medicineNF-E2-Related Factor 2PhysiologyClinical BiochemistryTriple Negative Breast NeoplasmsAKT DNMTs miR‐29b‐1‐5p NRF2 parthenolide tumor suppressor genesCell fate determinationenvironment and public healthDNA Methyltransferase 3A03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSettore BIO/10 - BiochimicaCell Line TumorCyclin D2HumansParthenolideDNA (Cytosine-5-)-MethyltransferasesProtein kinase BTriple-negative breast cancerCell Proliferationchemistry.chemical_classificationReactive oxygen speciesCell growthTumor Suppressor ProteinsCell BiologyDNA Methylationrespiratory systemCell biologyGene Expression Regulation NeoplasticMicroRNAs030104 developmental biologychemistryCell culture030220 oncology & carcinogenesisDNMT1FemaleReactive Oxygen SpeciesProto-Oncogene Proteins c-aktSesquiterpenesSignal TransductionJournal of Cellular Physiology
researchProduct

Dysregulation of DNA methylation induced by past arsenic treatment causes persistent genomic instability in mammalian cells

2015

The mechanisms by which arsenic-induced genomic instability is initiated and maintained are poorly understood. To investigate potential epigenetic mechanisms, in this study we evaluated global DNA methylation levels in V79 cells and human HaCaT keratinocytes at several time points during expanded growth of cell cultures following removal of arsenite exposures. We have found altered genomic methylation patterns that persisted up to 40 cell generations in HaCaT cells after the treatments were withdrawn. Moreover, mRNA expression levels were evaluated by RT-PCR for DNMT1, DNMT3A, DNMT3B, HMLH1, and HMSH2 genes, demonstrating that the down regulation of DNMT3A and DNMT3B genes, but not DNMT1, o…

DNA (Cytosine-5-)-Methyltransferase 1KeratinocytesDNA methylationArsenitesarsenicNuclear ProteinsFibroblastsgenomic instabilityArticleDNA Methyltransferase 3ASettore BIO/18 - GeneticaCricetulusLong Interspersed Nucleotide ElementsMutS Homolog 2 Protein5-MethylcytosineAnimalsDNA (Cytosine-5-)-MethyltransferasesMutL Protein Homolog 1Promoter Regions GeneticCells CulturedAdaptor Proteins Signal Transducing
researchProduct

Sex-specific windows for high mRNA expression of DNA methyltransferases 1 and 3A and methyl-CpG-binding domain proteins 2 and 4 in human fetal gonads

2006

DNA methyltransferases (DNMTs) and 5-methyl-CpG-binding domain proteins (MBDs) are involved in the acquisition of parent-specific epigenetic modifications in human male and female germ cells. Reverse Northern blot analyses demonstrated sex-specific differences in mRNA expression for the maintenance DNMT1 and the de novo DNMT3A in developing testis and ovary. In fetal testis DNMT1 and DNMT3A expression peaked in mitotically arrested spermatogonia around 21 weeks gestation. In fetal ovary transcriptional upregulation of DNMT1 and DNMT3A occurred during a very brief period at 16 weeks gestation, when the oocytes proceeded through meiotic prophase. Fetal gonads showed several fold higher DNMT3A…

DNA (Cytosine-5-)-Methyltransferase 1MaleMethyltransferaseEmbryonic DevelopmentGestational AgeOvaryBiologyGene Expression Regulation EnzymologicChromatin remodelingDNA Methyltransferase 3AFetal DevelopmentPregnancyTestisGeneticsmedicineHumansDNA (Cytosine-5-)-MethyltransferasesRNA MessengerEpigeneticsRegulation of gene expressionFetusReverse Transcriptase Polymerase Chain Reactionurogenital systemOvaryGene Expression Regulation DevelopmentalCell BiologyReverse northern blotMolecular biologyMethyl-CpG-binding domainCell biologyDNA-Binding Proteinsmedicine.anatomical_structureembryonic structuresFemaleTranscription FactorsDevelopmental BiologyMolecular Reproduction and Development
researchProduct

Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus.

2005

Abstract Background: Tacrolimus is metabolized predominantly to 13-O-demethyltacrolimus in the liver and intestine by cytochrome P450 3A (CYP3A). Patients with high concentrations of CYP3A5, a CYP3A isoenzyme polymorphically produced in these organs, require higher doses of tacrolimus, but the exact mechanism of this association is unknown. Methods: cDNA-expressed CYP3A enzymes and a bank of human liver microsomes with known CYP3A4 and CYP3A5 content were used to investigate the contribution of CYP3A5 to the metabolism of tacrolimus to 13-O-demethyltacrolimus as quantified by liquid chromatography–tandem mass spectrometry. Results: Demethylation of tacrolimus to 13-O-demethyltacrolimus was …

DNA ComplementaryCYP3AClinical BiochemistryPharmacologyBiologyIn Vitro Techniques030226 pharmacology & pharmacyTacrolimus03 medical and health sciences0302 clinical medicinePharmacokineticsCytochrome P-450 Enzyme SystemCytochrome P-450 CYP3AHumansCYP3A7030304 developmental biologyDemethylation0303 health sciencesCYP3A4Biochemistry (medical)MetabolismTacrolimusMicrosomeMicrosomes LiverBaculoviridaeImmunosuppressive AgentsClinical chemistry
researchProduct

Zvaigžņotā Debess: 2011, Vasara (212)

2011

Contents: “ZVAIGŽŅOTĀ DEBESS” FORTY YEARS AGO: A.Balklavs. Extremely Distant New Objects of Metagalaxy (abridged) ; Newspaper „Literaturnaja Rossija” 9 April 1971. Astronautics: Yesterday, Today, Tomorrow (abridged) ; CONFERENCE “The VIEW from SPACE. FIRST MANNED SPACE FLIGHT – 50”: M.Gills. Conference on the Eve of Human Space Flight Anniversary ; J.Ekmanis, S.Negrejeva. Mstislav Keldysh and Golden Age of Soviet Science ; T.Millers. Contribution of Scientists of the Institute of Inorganic Chemistry to the Development of Space Technologies and Materials ; G.Vilka. Remembrance of Friedrich Zander in Rīga ; O.Plepis. My Contribution to the Development of Space Medicine ; J.Stradiņš. Latvia’s …

Dauģēnu alas – garākās Baltijāno Candera līdz mūsdienām [Latvija kosmosa pētniecībā]Frīdrihs Canders – piemiņas vietas Rīgā un citurIzākam Rabinovičam – 100NASA infrasarkanais apskatnieks WISE – misijaKonkurss „Mums pieder debesis 2011” – noslēgumsRainis "Zvaigžņotā Debess" un DainasLatvijas studenti Mēness misijā ESMOKalendāri – sējai un ražai dvēselei un miesaiHabla Kosmiskais teleskops – 21. gadadienaMstislavs Keldišs – padomju zinātnes zelta gadiOsvalds Plēpis – kosmiskā medicīnaAndromedas miglājs M 31 infrasarkanajos optiskajos un rentgenstarosMarsa mobilis Curiosity – instrumentiLatvijas Astronomijas biedrības observatorija - SiguldaVistālākā galaktiku kopa CL J1449-0856Mārim Jansonam – 75Kosmonautikas pamatlicēji – pastmarkas aploksnesBrūno punduru dubultzvaigzne CFBDSIR J1458+1013ABAstronomiskās parādības – 2011 .gada vasarāNeorganiskās ķīmijas institūts – kosmosa tehnoloģijas materiāliEdgaram Bervaldam – 75Konference «Ar skatu no kosmosa. Pirmā cilvēka lidojumam kosmosā – 50»Astrofiziķe Zenta Alksne (29.07.1928.–6.03. 2011.)FOTONIKA-LV – FP7 projekts
researchProduct

Bounds for the relative n-th nilpotency degree in compact groups

2009

The line of investigation of the present paper goes back to a classical work of W. H. Gustafson of the 1973, in which it is described the probability that two randomly chosen group elements commute. In the same work, he gave some bounds for this kind of probability, providing information on the group structure. We have recently obtained some generalizations of his results for finite groups. Here we improve them in the context of the compact groups.

Degree (graph theory)Group (mathematics)General MathematicsProbability (math.PR)20P05 22A05 28C10 22A20 43A05Context (language use)Group Theory (math.GR)Group structureCombinatoricsLine (geometry)FOS: MathematicsMathematics - Group TheoryMathematics - ProbabilityHaar measureMathematics
researchProduct

CCDC 894411: Experimental Crystal Structure Determination

2013

Related Article: S.Fustero, P.Bello, J.Miro, M.Sanchez-Rosello, M.A.Maestro, J.Gonzalez, C.del Pozo|2013|Chem.Commun.|49|1336|doi:10.1039/c2cc37796a

Diethyl 10-methoxy-1-(4-methoxyphenyl)-26-bis(trifluoromethyl)-233a3b45611b-octahydro-1H-dipyrrolo[12-a:3'2'-c]quinoline-26-dicarboxylateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct